SMO and neoplasm: Conversely, the lack of the same mutation in cfDNA from patient #3 may be ascribed to the presence of not-tumor cfDNA confirmed by the presence of the p.Pro61Ala in the SMO gene (at an AF of 50%), as evidenced by the WES on PBMC of this patient.